Cystic Ileal Gastrointestinal Stromal Tumor Masquerading as Metastatic Adnexal Carcinoma

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46. https://doi.org/10.1016/j.canep.2015.10.031.

    Article  PubMed  Google Scholar 

  2. 2.

    Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006;30(4):477–89. https://doi.org/10.1097/00000478-200604000-00008.

    Article  PubMed  Google Scholar 

  3. 3.

    Feng F, Wang F, Wang Q, Zheng G, Xu G, Liu S, et al. Clinicopathological features and prognosis of gastrointestinal stromal tumor located in the jejunum and ileum. Dig Surg. 2019;36(2):153–7. https://doi.org/10.1159/000487147.

    Article  PubMed  Google Scholar 

  4. 4.

    Carlomagno G, Beneduce P. A gastrointestinal stromal tumor (GIST) masquerading as an ovarian mass. World J Surg Oncol. 2004;2(1):15. https://doi.org/10.1186/1477-7819-2-15.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Matteo D, Dandolu V, Lembert L, Thomas RM, Chatwani AJ. Unusually large extraintestinal GIST presenting as an abdomino-pelvic tumor. Arch Gynecol Obstet. 2008;278(1):89–92. https://doi.org/10.1007/s00404-007-0528-9.

    Article  PubMed  Google Scholar 

  6. 6.

    Zighelboim I, Henao G, Kunda A, Gutierrez C, Edwards C. Gastrointestinal stromal tumor presenting as a pelvic mass. Gynecol Oncol. 2003;91(3):630–5. https://doi.org/10.1016/j.ygyno.2003.08.025.

    Article  PubMed  Google Scholar 

  7. 7.

    Xue A, Yuan W, Gao X, Fang Y, Shu P, Xu C, et al. Gastrointestinal stromal tumors (GISTs) with remarkable cystic change: a specific subtype of GISTs with relatively indolent behaviors and favorable prognoses. J Cancer Res Clin Oncol. 2019;145(6):1559–68. https://doi.org/10.1007/s00432-019-02853-y.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Rubini P, Tartamella F. Primary gastrointestinal stromal tumour of the ileum pre-operatively diagnosed as an abdominal abscess. Mol Clin Oncol. 2016;5(5):596–8. https://doi.org/10.3892/mco.2016.1009.

    Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Sripathi S, Rajagopal K, Srivastava RK, Ayachit A. CT features, mimics and atypical presentations of gastrointestinal stromal tumor (GIST). Indian J Radiol Imaging. 2011;21(3):176–81. https://doi.org/10.4103/0971-3026.85364.

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Bechtold R, Chen M, Stanton C, Savage P, Levine E. Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec. Abdom Imaging. 2003;28(6):808–14. https://doi.org/10.1007/s00261-003-0021-2.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Shi Y-N, Li Y, Wang L-P, Wang Z-H, Liang X-B, Liang H, et al. Gastrointestinal stromal tumor (GIST) with liver metastases: an 18-year experience from the GIST cooperation group in North China. Medicine. 2017;96(46):e8240. https://doi.org/10.1097/MD.0000000000008240.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Vassos N, Agaimy A, Hohenberger W, Croner RS. Management of liver metastases of gastrointestinal stromal tumors (GIST). Ann Hepatol. 2015;14(4):531–9. https://doi.org/10.1016/S1665-2681(19)31175-5.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Gupta P, Tewari M, Shukla HS. Gastrointestinal stromal tumor. Surg Oncol. 2008;17(2):129–38. https://doi.org/10.1016/j.suronc.2007.12.002.

    Article  PubMed  Google Scholar 

  14. 14.

    Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39(10):1411–9. https://doi.org/10.1016/j.humpath.2008.06.025.

    Article  PubMed  Google Scholar 

  15. 15.

    Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, et al. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20(9):2937–43. https://doi.org/10.1245/s10434-013-3013-7.

    Article  PubMed  Google Scholar 

  16. 16.

    Tielen R, Verhoef C, van Coevorden F, Gelderblom H, Sleijfer S, Hartgrink H, et al. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Eur J Surg Oncol. 2013;39(2):150–5. https://doi.org/10.1016/j.ejso.2012.09.004.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    DeMatteo RP, Ballman KV, Antonescu CR, Corless C, Kolesnikova V, Von Mehren M, et al. Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor (GIST): ACOSOG Z9000 (Alliance) intergroup phase 2 trial. Ann Surg. 2013;258(3):422–9. https://doi.org/10.1097/SLA.0b013e3182a15eb7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Blanke CD, Rankin C, Demetri GD, Ryan CW, Von Mehren M, Benjamin RS, et al. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol. 2008;26(4):626–32. https://doi.org/10.1200/JCO.2007.13.4452.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Demetri GD, Von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347(7):472–80. https://doi.org/10.1056/NEJMoa020461.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Oppelt PJ, Hirbe AC, Van Tine BA. Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review. J Gastrointest Oncol. 2017;8(3):466–73. https://doi.org/10.21037/jgo.2016.09.15.

    Article  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Le Cesne A, Ray-Coquard I, Bui BN, Adenis A, Rios M, Bertucci F, et al. Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. Lancet Oncol. 2010;11(10):942–9. https://doi.org/10.1016/S1470-2045(10)70222-9.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Kunal Bikram Deo.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Deo, K.B., Gautam, S., Awale, L. et al. Cystic Ileal Gastrointestinal Stromal Tumor Masquerading as Metastatic Adnexal Carcinoma. J Gastrointest Canc 51, 1053–1056 (2020). https://doi.org/10.1007/s12029-020-00403-1

Download citation